Back to Journals » Drug Design, Development and Therapy » Volume 18

5-Fluorouracil Combined with Rutaecarpine Synergistically Suppresses the Growth of Colon Cancer Cells by Inhibiting STAT3 [Retraction]

Authors Yu Z , Chan S, Wang X, Sun R, Wang M , Wang Z, Zuo X , Chen J, Zhang H, Chen W

Received 17 June 2024

Accepted for publication 17 June 2024

Published 19 June 2024 Volume 2024:18 Pages 2403—2404

DOI https://doi.org/10.2147/DDDT.S483041



Yu Z, Chan S, Wang X, et al. Drug Des Devel Ther. 2023;17:993–1006.

At the authors request, the Editor and Publisher of the journal Drug Design, Development and Therapy have retracted the published article.

Following publication of the article, the authors raised concerns about the duplication of images from Figure 4. Specifically,

  • The images for Figure 4G, HCT116, RUT and 5-FU, have been duplicated.

The authors wished to apologize for this error and no longer have confidence in the data and corresponding findings. To maintain academic standards, the authors requested to retract the article and the Editor and Publisher agreed with this decision.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.